Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Optimer Pharmaceuticals Inc (OPTR) since 2010 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Optimer Pharmaceuticals Inc. Table 2 shows the detailed insider transactions. This company's CIK number is 1142576.
Total stock buying since 2010: $361,512.
Total stock sales since 2010: $2,320,190.
Total stock option exercises since 2010: $7,659,906.
▪ Recent SEC 13D filings for all companies
▪ Recent portfolio reports of all companies
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2013 | 0 | $0 | 148,000 | $2,172,344 | 795,315 | $7,398,410 |
| 2012 | 11,000 | $99,847 | 3,461 | $52,953 | 3,461 | $2,249 |
| 2011 | 30,000 | $261,665 | 0 | $0 | 200,000 | $216,600 |
| 2010 | 0 | $0 | 8,076 | $94,893 | 28,218 | $42,647 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2013-09 | 0 | $0 | 0 | $0 | 281,615 | $2,361,623 |
| 2013-04 | 0 | $0 | 148,000 | $2,172,344 | 513,700 | $5,036,787 |
| 2012-11 | 11,000 | $99,847 | 0 | $0 | 0 | $0 |
| 2012-06 | 0 | $0 | 3,461 | $52,953 | 3,461 | $2,249 |
| 2011-08 | 30,000 | $261,665 | 0 | $0 | 0 | $0 |
| 2011-04 | 0 | $0 | 0 | $0 | 200,000 | $216,600 |
| 2010-08 | 0 | $0 | 0 | $0 | 6,298 | $9,094 |
| 2010-06 | 0 | $0 | 0 | $0 | 13,844 | $30,040 |
| 2010-05 | 0 | $0 | 8,076 | $94,893 | 8,076 | $3,513 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2013-09-04 | Chang Michael N (Director) | Option Ex | 281,615 | 8.39 | 2,361,623 |
| 2013-04-23 | Chang Michael N (Director) | Option Ex | 117,263 | 1.08 | 126,995 |
| 2013-04-09 | Chang Michael N (Director) | Option Ex | 103,125 | 12.34 | 1,272,562 |
| 2013-04-08 | Lichtinger Pedro (Other) | Sale | 148,000 | 14.68 | 2,172,344 |
| 2013-04-08 | Lichtinger Pedro (Other) | Option Ex | 148,000 | 12.46 | 1,844,080 |
| 2013-04-03 | Chang Michael N (Director) | Option Ex | 145,312 | 12.34 | 1,793,150 |
| 2012-11-08 | Lichtinger Pedro (CEO and President) | Buy | 11,000 | 9.08 | 99,847 |
| 2012-06-11 | Chang Joseph Y (Director) | Sale | 3,461 | 15.30 | 52,953 |
| 2012-06-11 | Chang Joseph Y (Director) | Option Ex | 3,461 | .65 | 2,249 |
| 2011-08-09 | Altig Anthony E (Director) | Buy | 5,000 | 7.44 | 37,215 |
| 2011-08-04 | Lichtinger Pedro (CEO and President) | Buy | 25,000 | 8.98 | 224,450 |
| 2011-04-25 | Chang Michael N (Director) | Option Ex | 100,000 | 1.08 | 108,300 |
| 2011-04-25 | Che Tessie M (COO and SVP) | Option Ex | 100,000 | 1.08 | 108,300 |
| 2010-08-30 | Shue Youe Kong (VP, Clinical Development) | Option Ex | 6,298 | 1.44 | 9,094 |
| 2010-06-01 | Chang Michael N (Director) | Option Ex | 6,922 | 2.17 | 15,020 |
| 2010-06-01 | Che Tessie M (COO and SVP) | Option Ex | 6,922 | 2.17 | 15,020 |
| 2010-05-12 | Chang Joseph Y (Director) | Sale | 8,076 | 11.75 | 94,893 |
| 2010-05-12 | Chang Joseph Y (Director) | Option Ex | 8,076 | .43 | 3,513 |
Insider trading activities including stock purchases, stock sales, and option exercises of OPTR listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Optimer Pharmaceuticals Inc (symbol OPTR, CIK number 1142576) see the Securities and Exchange Commission (SEC) website.